In a laboratory setting, Mayo Clinic researchers have found that a combination of a drug used to treat rheumatoid arthritis and an experimental agent shut down a common and aggressive type of lung cancer.
In this Mayo Clinic Minute, reporter Vivien Williams talks to Dr. Alan Fields about the new drug combo and what it may mean for patients.
More health and medical news on the Mayo Clinic News Network [ Ссылка ]
